1 simple treatmentrelieves OA painup to 1 full year
NEW Synovetin OA® breaks the cycle of inflammation and pain, clinically improving mobility and providing long-lasting relief.
Synovetin OA® is a veterinary device that uses novel, conversion electron therapy to target macrophages and synoviocytes in the injected joint.1,2
Provides durable pain and inflammation relief
Restores the active lifestyle of dogs with their families
Alters the course of chronic OA treatment
The chronic pain of OA is one of the most significant, debilitating conditions in companion animal health3
Enormous opportunity exists to address the untreated population.
~2 million Dogs
are referred to specialists each year4
Only ~900K of these actually see a specialist
Only ~600K of these seen are eventually treated
Experts share their challenges in treating canine elbow osteoarthritis (OA)
Delivers sustained, long-term relief2
Helps you more confidently manage patients
Answers a significant unmet need
Helps improve your canine patient's quality of life3
Provides targeted, non-systemic therapy1
Breaks the inflammatory cycle and improves mobility2
References:
- Fox SM, Donecker JM. Synovitis Technical Bulletin. Exubrion Therapeutics® July 2019.
- Data on File, Exubrion Therapeutics®.
- American College of Veterinary Surgeons. Canine elbow dysplasia. Available at: https://www.acvs.org/small-animal/canine-elbow-dysplasia. Accessed 5/15/19.
